Vasodilator effect and mechanism of action of vascular endothelial growth factor in skin vasculature (Q44673746)

5 December 2017

Vasodilator effect and mechanism of action of vascular endothelial growth factor in skin vasculature (English)

1 reference

5 December 2017

0 references

Homa Ashrafpour

1

1 reference

5 December 2017

Ning Huang

2

1 reference

5 December 2017

Peter C Neligan

3

1 reference

5 December 2017

Christopher R Forrest

4

1 reference

5 December 2017

Patrick D Addison

5

1 reference

5 December 2017

Michael A Moses

6

1 reference

5 December 2017

Ronald H Levine

7

1 reference

5 December 2017

Cho Y Pang

8

1 reference

5 December 2017

26 November 2003

1 reference

American Journal of Physiology Heart and Circulatory Physiology

5 December 2017

1 reference

5 December 2017

286

1 reference

5 December 2017

3

1 reference

5 December 2017

H946-54

1 reference

Effect of nicotine on vasoconstrictor and vasodilator responses in human skin vasculature

5 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

Structural mechanisms of acute VEGF effect on microvessel permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

Effect of transfection time on the survival of epigastric skin flaps pretreated with adenovirus encoding the VEGF gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

Comparison of secondary ischemic tolerance between pedicled and free island buttock skin flaps in the pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

The effects of VEGF on survival of a random flap in the rat: examination of various routes of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

KDR (VEGF receptor 2) is the major mediator for the hypotensive effect of VEGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

Vascular endothelial growth factor-mediated, endothelium-dependent relaxation in human internal mammary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

Pyridostigmine bromide modulates topical irritant-induced cytokine release from human epidermal keratinocytes and isolated perfused porcine skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

Vascular endothelial growth factor gene therapy in ischaemic rat skin flaps

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

Amplification effect and mechanism of action of ET-1 in U-46619-induced vasoconstriction in pig skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

Activities of endothelin-1 in the vascular network of the rabbit ear: a microangiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00901.2003

10.1152/AJPHEART.00901.2003

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference